Abeona Therapeutics Inc. (ABEO) vs Evommune Inc. (EVMN)
Abeona Therapeutics Inc. and Evommune Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Evommune Inc. are of similar size ($309.9M and $303.8M). Evommune Inc. has the higher net margin (0.00% vs −242.6%) and the lower return on invested capital (−82.5% vs 0.00%). Across the 13 metrics below, Evommune Inc. leads on 8 and Abeona Therapeutics Inc. on 5.
Valuation
Profitability
| Metric | ABEO | EVMN | Biotechnology median |
|---|---|---|---|
| Gross margin | 66.03% | — | 65.16% |
| Operating margin | (322.59%) | 0.00% | 0.00% |
| Net margin | (242.62%) | 0.00% | 0.00% |
| Free cash flow margin | (314.53%) | 0.00% | 0.00% |
| Return on equity | (43.13%) | (141.99%) | (57.72%) |
| Return on assets | (29.54%) | (62.71%) | (49.22%) |
| Return on invested capital | 0.00% | (82.46%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack